A Philadelphia jury returned a $28 million punitive damages verdict Monday against two drugmakers over the drugmakers’ hormone-replacement therapy drugs that the jury found caused a plaintiff’s breast cancer.

And a $75 million punitive damages verdict from the end of October in another hormone-replacement therapy, or HRT, mass tort case was unsealed by court order after the other jury verdict was rendered around 2 p.m. Monday.